Prof Michael Seckl (Imperial College London, London, UK) introduces the upcoming meeting 'Future Horizons in Lung Cancer' coming to the Royal Society of Medicine in London on 1-2 September 2016.

But why should healthcare professionals be interested in this event? Prof Seckl explains what is unique and essential about this exciting meeting.

Prof Seckl and Prof Gordon McVie have jointly developed a programme covering the role of immunotherapy, new molecular target agents and resection for lung cancer, as well as offering over 20 internationally recognised speakers.

To register, go to the website